A Single-centre, Open-label, Single-dose Interventional Study Investigating the Pharmacokinetic Properties of Lu AA21004 in Healthy Young Chinese Men and Women
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Vortioxetine (Primary)
- Indications Anxiety disorders; Depressive disorders; Generalised anxiety disorder; Major depressive disorder
- Focus Pharmacokinetics
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2012 Planned initiation date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.